Recombinant Factor VIIA, its Clinical Properties, and the Tissue Factor Pathway of Coagulation

E-ISSN： 1875-5607|6|10|1111-1117

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.10, 2006-10, pp. : 1111-1117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin: Blood coagulation disorders treated with recombinant factor VIIa: case report

Reactions Weekly, Vol. 1, Iss. 1375, 2011-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Modulators of the Coagulation Cascade: Focus and Recent Advances in Inhibitors of Tissue Factor, Factor VIIa and their Complex

Current Medicinal Chemistry, Vol. 12, Iss. 4, 2005-02 ,pp. : 397-417

Bentham Science Publishers

Access to resources Recommend Favorite

Clopidogrel/recombinant factor VIIa: Disseminated intravascular coagulation-like phenomenon and aortic valve thrombosis: case report

Reactions Weekly, Vol. 1, Iss. 1402, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

New Insights into the Coagulation System and Implications for New Therapeutic Options with Recombinant Factor VIIa

Current Medicinal Chemistry, Vol. 10, Iss. 10, 2003-05 ,pp. : 797-811

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Tissue Factor•Factor VIIa for Anticoagulant Therapy

Current Medicinal Chemistry, Vol. 11, Iss. 17, 2004-09 ,pp. : 2275-2290

Bentham Science Publishers

Access to resources Recommend Favorite